New Zealand's benchmark index hit a new 52-week high Friday, buoyed by an upgraded earnings guidance from a2 Milk Company (NZE:ATM, ASX:A2M).
The S&P/NZX 50 Index rose 2.2%, or 276.66 points, to close at 13,041.90. The index has gained 2% over the last five trading days.
Consumer non-durables led the increase as stocks climbed more than 5%. Health technology and non-energy minerals shares followed, with gains of over 3% each.
a2 Milk soared almost 16% after it upgraded its fiscal 2025 year-on-year revenue growth guidance to "mid to high single-digit revenue growth" from "mid single-digit growth."
The company attributed the revised outlook to a significant increase in Mataura Valley Milk external ingredient sales.
In other corporate news, Oceania Healthcare (NZE:OCA, ASX:OCA) fell 5% after it reported a loss of NZ$0.024 per share for the six months ended Sept. 30, compared with earnings of NZ$0.049 per share a year earlier.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.